3-(1H-Pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A

Journal of Medicinal Chemistry

Volumn 45, Issue 6, 2002, Pages 1180-1183

  Mai, Antonello ^a   Artico, Marino ^a   Esposito, Monica ^a   Sbardella, Gianluca ^b   Massa, Silvio ^c   Befani, Olivia ^a   Turini, Paola ^a   Giovannini, Valentina ^a   Mondovi, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXYMETHYL 3 (1H PYRROL 1 YL) 2 OXAZOLIDINONE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MONOAMINE OXIDASE A INHIBITOR; OXAZOLIDINONE DERIVATIVE; PYRROLE DERIVATIVE; TOLOXATONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; EVALUATION;

HUMANS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; OXAZOLIDINONES; PYRROLES;

EID: 0037075787     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm015578d     Document Type: Article

References (31)

1. The covalently bound flavin of hepatic monoamine oxidase. Isolation and sequence of a flavin peptide and evidence of a binding at the 8-a position
2. Localization of monoamine oxidase in rat liver mitochondria
3. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid
4. Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism
5. Distinct monoamine oxidase A and B populations in primate brain
6. Tissue distribution of human monoamine oxidase A and B mRNA
7. Some observations upon a new inhibitor of monoamine oxidase in brain tissue
8. Protection against apoptosis by monoamine oxidase A inhibitors
9. Phenyl-isopropylmethyl-propinylamine (E-250), a new psychic energizer
10. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease
11. The new generation of monoamine oxidase inhibitors
12. Monoamine oxidase: From physiology and pathophysiology to the design and clinical application of reversible inhibitors
13. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A
14. The monoamine oxidase inhibiting properties of CGP 11305 A
15. From moclobemide to Ro 19-6327 and Ro 41-1049: The development of a new class of reversible, selective MAO-A and MAO-B inhibitors
16. Interactions of monoamine oxidase with substrates and inhibitors
17. Effects of a new antidepressant (3-methyl)-3-phenyl -5-hydroxymethyl-2-oxazolidinone (toloxatone) upon 5-hydroxytryptamine pathways
18. A reversible monoamine oxidase inhibitor, toloxaton: Structural and electronic properties
19. A reversible monoamine oxidase inhibitor, Toloxatone: Spectrophotometric and molecular orbital studies of the interaction with flavin adenine dinucleotide (FAD)
20. A reversible monoamine oxidase inhibitor, Toloxatone: Comparison of its physicochemical properties with those of other inhibitors including Brofaromine, Harmine, R40519 and Moclobemide
21. Befloxatone
22. A reversible monoamine oxidase A inhibitor, Befloxatone: Structural approach of its mechanism of action
23. Synthesis of new tetracyclic system related to aptazapine (CGS 7525A) by one-pot double annelation
24. Synthesis of 3b,4,6,7-tetrahydro-5H,9H-pyrazino[2,1-c]pyrrolo[1,2-a][1,4]-benzodiazepine, a valuable precursor of potential central nervous system agents
25. Pyrrolobenzodiazepines and related systems. 2. Synthesis and biological properties of isonoraptazepine derivatives
26. Pyrrolobenzodiazepines azepines with antinociceptive activity: Synthesis and pharmacological activities
27. Cyclische Verbindungen mit Heterobruckenatomen, V. Zur Chemie der 1-Amino-pyrrole
28. Brain mitochondria. I. Isolation of bovine brain mitochondria
29. A sensitive fluorimetric assay for serum monoamino oxidase with kynuramine as substrate